New insider activity at Sally Beauty ( (SBH) ) has taken place on December 3, 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Scott C Sherman, the Senior Vice President, Chief Legal Officer, and Chief Human Resources Officer of Sally Beauty, recently sold 15,000 shares of the company’s stock. This transaction was valued at $244,050.
Recent Updates on SBH stock
Sally Beauty Holdings has recently seen a positive shift in its stock price targets due to strong financial performance and strategic growth initiatives. The company’s Q4 earnings report highlighted a 1.3% increase in consolidated net sales and a 10% rise in adjusted diluted EPS, reflecting robust financial health. Analysts have raised price targets, citing the company’s successful expansion in e-commerce and color segments, as well as strategic initiatives like the ‘Fuel for Growth’ program, which generated significant incremental benefits. Despite challenges such as a decline in the care category and flat comparable transactions, Sally Beauty’s focus on digital transformation and strategic investments positions it well for continued success. The company’s forward-looking guidance for fiscal 2026 indicates confidence in achieving sustained growth and profitability.
Spark’s Take on SBH Stock
According to Spark, TipRanks’ AI Analyst, SBH is a Outperform.
Sally Beauty’s overall stock score reflects strong earnings performance and attractive valuation. The company’s strategic initiatives and robust cash flow generation provide a solid foundation for future growth. While technical indicators are mixed, the positive earnings outlook and undervaluation are significant strengths.
To see Spark’s full report on SBH stock, click here.
More about Sally Beauty
YTD Price Performance: 48.13%
Average Trading Volume: 2,133,535
Technical Sentiment Signal: Buy
Current Market Cap: $1.54B

